LifeNet Health’s 3D HuBiogel™ supports the only fully-human, tissue-like bioassay system for accelerating preclinical research and drug development. Our proprietary cell culture technology replicates the biology and microenvironment of normal and diseased tissues ex vivo, and a series of high-throughput microtumor culture/assay systems offer rapid yet accurate efficacy evaluation of preclinical drug candidates and prediction of their potential toxicity.
The LifeSciences Division offers a range of services including:
- 3D microtumor bioassay
- Real-time drug sensitivity
- Predictive preclinical drug screening